PERCEPTIVE ADVISORS LLC 13D and 13G filings for Coherus BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-5,407,798 (Position Closed) |
Filing |
| 2022-02-14 6:33 pm Purchase |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 5,407,798 7.000% |
735,962 (+15.75%) |
Filing |
| 2021-02-16 3:36 pm Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 4,671,836 6.500% |
1,085,351 (+30.26%) |
Filing |
| 2020-10-07 4:30 pm Purchase |
2020-09-29 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 3,586,485 5.000% |
3,586,485 (New Position) |
Filing |